Key policies and measures of HIV/AIDS prevention and control at global level

Author:

Baroš Slađana,Šipetić-Grujičić SandraORCID

Abstract

During the last 40 years, the development of medical HIV and AIDS related knowledge has been followed by a coordinated international HIV response, in terms of developing policies and measures for the HIV/AIDS prevention and control based on evidence from public health and clinical studies. The HIV response can be divided into three periods: the period of HIV response establishment (1981-1996); the period of multi-sectoral response (1996-2007) and the period of strengthening biomedical measures for HIV prevention (2007 and beyond). International policies and recommended HIV prevention measures have undergone a series of transformations, from the establishment of the first organized and coordinated national programs, to the design and implementation of innovative biomedical prevention measures, such as voluntary medical circumcision, pre-exposure prophylaxis and the implementation of the "test and treat" measure - the introduction of antiretroviral therapy immediately after diagnosing HIV infection to achieve undetectable viral load. New findings on successful use of antiretroviral therapy as prevention led to the formulation of goals for 2020: 90% of all people living with HIV to know their HIV status, 90% of them to receive antiretroviral therapy, and 90% of them to have viral suppression; to have less than 500 000 of both newly HIV infected persons, and AIDS related deaths. Despite of the HIV response major improvements, such as development and implementation of multisectoral national HIV/AIDS policies on prevention and control, the 2020 goals have not been meet. For achieving the main goal - ending AIDS as public health threat by 2030 - implementation of all recommended biomedical, behavioral and structural interventions should be intensified.

Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Subject

General Medicine

Reference54 articles.

1. Visseaux B, Damond F, Matheron S, Descamps D, Charpentier C. HIV-2 molecular epidemiology. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2016; 46:233-40;

2. Simić D. Epidemiološke odlike infekcije virusom humane imunodeficijencije i sindroma stečene imunodeicijencije. U: Jevtović Đ, urednik. HIV infekcija: Priručnik za lekare. Beograd: Institut za javno zdravlje Srbije "Dr Milan Jovanović Batut"; 2007. 6-20;

3. Jevtović Đ. HIV infekcija: Početni pristup i dalji tretman pacijenata sa infekcijom virusom humane imunodeficijencije. U: Jevtović Đ, urednik. HIV infekcija: priručnik za lekare. Beograd: Institut za javno zdravlje Srbije "Dr Milan Jovanović Batut";2007. 31-46;

4. Centers for Disease Prevention and Control. Ways HIV can be transmitted [Internet]; Atlanta, USA: CDC; 2022 [ažurirano 4. mart 2022, pristupljeno 11. avgust 2022]. Dostupno na: https:// www.cdc.gov/hiv/basics/hiv-transmission/ways-people-get-hiv.html;

5. Joint United Nations Programme on HIV/AIDS. Fact sheet 2022: Latest global and regional statistics on the status of the AIDS epidemic [Internet];

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3